Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Seizure Therapy for Parkinson's Disease

NCT04784494 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04784494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04784494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Seizure Therapy for Parkinson's Disease
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 20, 2021
Completion date
February 28, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, major depressive disorder, movement disorders, parkinson disease